Authors




Leslie Cantu

Latest:

MUSC Pilot Program Shows Success in Treating Opioid Users

Research demonstrates that medication-assisted treatment for opioid addiction works, yet few have adopted it.


Linda Rogers, RN, MBA, CPA

Latest:

Our Move to an EHR

The initial capital outlay for transitioning to an EHR is not small. In fact, cost is one of the main reasons practices have been slow to adopt EHRs.



Don Poldermans, MD3: From the 1Department of Vascular Surgery, 2Department of Cardiology, 3Department of Anesthesio

Latest:

Are statins cardioprotective in patients undergoing major vascular surgery?

We evaluated the cardioprotective effects of intensive statin therapy before major vascular surgery in a prospective study of 359 subjects. After multivariate analysis, lower low-density lipoprotein (LDL) cholesterol was associated with decreased myocardial ischemia, troponin T release, and 30-day and late cardiac events. Furthermore, higher doses of statins were associated with better cardiac outcome, even after adjusting for LDL cholesterol.


Stephen C. Vlay, MD is professor of medicine at State University of New York, Stony Brook, New York.

Latest:

Radiofrequency ablation vs medical therapy after a first episode of symptomatic atrial flutter

Atrial flutter is an arrhythmia that occurs less commonly than atrial fibrillation and is often resistant to rate control and termination.




Josh Weiner, President & CEO of Solutionreach

Latest:

Maximize Your Digital Front Door During COVID-19

A look at the available and viable tools to continue patient access and care.





Peter H. Jones, MD, is associate professor, Center for Cardiovascular Disease Prevention, Baylor College of Medicine, Houston, TX.

Latest:

Lipoprotein(a) and coronary artery disease:

The well-established causative role of low-density lipoprotein particles in atherosclerotic plaque development has led to this biomarker being a primary target of treatment in the prevention of coronary artery disease.


Aileen M. Soper, BA

Latest:

NOW Initiative: Payer & Provider Collaborations in Oncology Benefits Management

Payers recognize the need to expand benefits management for oncology but struggle to find effective solutions amid the complexity of available therapies and skepticism from oncologists, who are facing their own set of economic pressures. The National Oncology Working Group (NOW) Initiative is trying to change the sometimes adversarial relationship between payers and oncologists through a collaborative model.


Charles Q. Choi of Scientific American

Latest:

Psoriasis Linked to Protection from HIV-1

Many psoriasis patients have the same gene variants as people who are not significantly affected by an HIV-1 infection.





Roshni Patel, BSc (Hons), MCOptom

Latest:

Roshni Patel, BSc, MCOptom: The State of Glaucoma in 2020

An optometrist from Europe discusses the current state of glaucoma from identification to treatment.


RDR Staff

Latest:

NDA for NTM Lung Disease Treatment Submitted to FDA

Insmed Incorporated announced that it has submitted its New Drug Application for amikacin liposome inhalation suspension (ALIS) to the U.S. FDA.


Alex Abou-Chebl, MD, is director of neurointerventional services, University of Louisville Hospital

Latest:

Patent foramen ovale closure for stroke prevention: A myriad of unanswered questions

Migraines, including those with aura, are common and generally benign, affecting between 10% and 15% of the population.


John Tarpley, Margaret Tarpley, Donald Meier

Latest:

Operating in the Global Theater

Two American couples share what they have learned in over 20 cumulative years of treating the world's neediest patients and detail what it takes to become a successful volunteer surgeon.




Clinics, Iowa City,

Latest:

Heart failure and sudden death in patients with tachycardia-induced cardiomyopathy and recurrent tachycardia

The effects of recurrent tachycardia after resolution of cardiomyopathy have not been thoroughly assessed. We evaluated and followed 24 patients with tachycardia-induced cardiomyopathy for more than 12 years. Our observations showed that patients with tachycardia-induced cardiomyopathy may be at long-term risk for sudden death. Surreptitious cardiomyopathy due to occult ultrastructural changes may persist. It has yet to be determined whether rapid and aggressive rate control would prevent structural damage to risk of sudden cardiac death.




Ping Zhang, PhD

Latest:

Effectiveness and Cost-Effectiveness of Diabetes Prevention among Adherent Participants

Over 10 years, lifestyle intervention and metformin were cost-effective or cost saving compared with placebo.


Laura Carabello

Latest:

Without the Affordable Care Act Will Medical Tourism Increase?

Medical tourism could soon increase. What's that mean for US doctors?

© 2024 MJH Life Sciences

All rights reserved.